Abstract
Platelet aggregation by bacteria is felt to play an important role in the pathogenesis of infective endocarditis. However, the mechanisms involved in bacterium-induced platelet aggregation are not well-defined. In the present study, we examined the mechanisms by which Staphylococcus aureus causes rabbit platelet aggregation in vitro. In normal plasma, the kinetics of S. aureus-induced platelet aggregation were rapid and biphasic. The onset and magnitude of aggregation phase 1 varied with the bacterium-platelet ratio, with maximal aggregation observed at a ratio of 5:1. The onset of aggregation phase 2 was delayed in the presence of apyrase (an ADP hydrolase), suggesting that this later aggregation phase may be triggered by secreted ADP. The onset of aggregation phase 2 was delayed in the presence of prostaglandin I2-treated platelets, and this phase was absent when paraformaldehyde-fixed platelets were used, implicating platelet activation in this process. Platelet aggregation phase 2 was dependent on S. aureus viability and an intact bacterial cell wall, and it was mitigated by antibody directed against staphylococcal clumping factor (a fibrinogen-binding protein) and by the cyclooxygenase inhibitor indomethacin. Similarly, aggregation phase 2 was either delayed or absent in three distinct transposon-induced S. aureus mutants with reduced capacities to bind fibrinogen in vitro. In addition, a synthetic pentadecapeptide, corresponding to the staphylococcal binding domain in the C terminus of the fibrinogen delta-chain, blocked aggregation phase 2. However, phase 2 of aggregation was not inhibited by two synthetic peptides (alone or in combination) analogous to the two principal fibrinogen-binding domains on the platelet glycoprotein (GP) IIb/IIIa integrin receptor: (i) a recognition site on the IIIa molecule for the Arg-Gly-Asp (RGD) sequence of the fibrinogen alpha-chain and (ii) a recognition site on the IIb molecule for a dodecapeptide sequence of the fibrinogen delta-chain. This differs from ADP-induced platelet aggregation, which relies on an intact platelet GP IIb/IIIa receptor with an accessible RGD sequence and dodecapeptide recognition site for fibrinogen. Furthermore, a monoclonal antibody directed against the RGD recognition site on rabbit platelet GP IIb/IIIa receptors failed to inhibit rabbit platelet aggregation by S. aureus. Collectively, these data suggest that S. aureus-induced platelet aggregation requires bacterial binding to fibrinogen but is not principally dependent upon the two major fibrinogen-binding domains on the platelet GP IIb/IIIa integrin receptor, the RGD and dodecapeptide recognition sites.
Full Text
The Full Text of this article is available as a PDF (251.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Azrin M. A., Ling F. S., Chen Q., Pawashe A., Migliaccio F., Homer R., Todd M., Ezekowitz M. D. Preparation, characterization, and evaluation of a monoclonal antibody against the rabbit platelet glycoprotein IIb/IIIa in an experimental angioplasty model. Circ Res. 1994 Aug;75(2):268–277. doi: 10.1161/01.res.75.2.268. [DOI] [PubMed] [Google Scholar]
- Cheresh D. A., Berliner S. A., Vicente V., Ruggeri Z. M. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell. 1989 Sep 8;58(5):945–953. doi: 10.1016/0092-8674(89)90946-x. [DOI] [PubMed] [Google Scholar]
- Cheung A. L., Eberhardt K. J., Chung E., Yeaman M. R., Sullam P. M., Ramos M., Bayer A. S. Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Invest. 1994 Nov;94(5):1815–1822. doi: 10.1172/JCI117530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cheung A. L., Koomey J. M., Butler C. A., Projan S. J., Fischetti V. A. Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6462–6466. doi: 10.1073/pnas.89.14.6462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cheung A. L., Krishnan M., Jaffe E. A., Fischetti V. A. Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J Clin Invest. 1991 Jun;87(6):2236–2245. doi: 10.1172/JCI115259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cheung A. L., Wolz C., Yeaman M. R., Bayer A. S. Insertional inactivation of a chromosomal locus that modulates expression of potential virulence determinants in Staphylococcus aureus. J Bacteriol. 1995 Jun;177(11):3220–3226. doi: 10.1128/jb.177.11.3220-3226.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cheung A. L., Yeaman M. R., Sullam P. M., Witt M. D., Bayer A. S. Role of the sar locus of Staphylococcus aureus in induction of endocarditis in rabbits. Infect Immun. 1994 May;62(5):1719–1725. doi: 10.1128/iai.62.5.1719-1725.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clawson C. C., White J. G., Herzberg M. C. Platelet interaction with bacteria. VI. contrasting the role of fibrinogen and fibronectin. Am J Hematol. 1980;9(1):43–53. doi: 10.1002/ajh.2830090106. [DOI] [PubMed] [Google Scholar]
- Coburn J., Barthold S. W., Leong J. M. Diverse Lyme disease spirochetes bind integrin alpha IIb beta 3 on human platelets. Infect Immun. 1994 Dec;62(12):5559–5567. doi: 10.1128/iai.62.12.5559-5567.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Drake T. A., Pang M. Staphylococcus aureus induces tissue factor expression in cultured human cardiac valve endothelium. J Infect Dis. 1988 Apr;157(4):749–756. doi: 10.1093/infdis/157.4.749. [DOI] [PubMed] [Google Scholar]
- Durack D. T., Beeson P. B. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br J Exp Pathol. 1972 Feb;53(1):44–49. [PMC free article] [PubMed] [Google Scholar]
- Durack D. T. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions. J Pathol. 1975 Feb;115(2):81–89. doi: 10.1002/path.1711150204. [DOI] [PubMed] [Google Scholar]
- Espersen F., Clemmensen I., Barkholt V. Isolation of Staphylococcus aureus clumping factor. Infect Immun. 1985 Sep;49(3):700–708. doi: 10.1128/iai.49.3.700-708.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Farrell D. H., Thiagarajan P., Chung D. W., Davie E. W. Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10729–10732. doi: 10.1073/pnas.89.22.10729. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Herrmann M., Lai Q. J., Albrecht R. M., Mosher D. F., Proctor R. A. Adhesion of Staphylococcus aureus to surface-bound platelets: role of fibrinogen/fibrin and platelet integrins. J Infect Dis. 1993 Feb;167(2):312–322. doi: 10.1093/infdis/167.2.312. [DOI] [PubMed] [Google Scholar]
- Herzberg M. C., Brintzenhofe K. L., Clawson C. C. Aggregation of human platelets and adhesion of Streptococcus sanguis. Infect Immun. 1983 Mar;39(3):1457–1469. doi: 10.1128/iai.39.3.1457-1469.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Herzberg M. C., Gong K., MacFarlane G. D., Erickson P. R., Soberay A. H., Krebsbach P. H., Manjula G., Schilling K., Bowen W. H. Phenotypic characterization of Streptococcus sanguis virulence factors associated with bacterial endocarditis. Infect Immun. 1990 Feb;58(2):515–522. doi: 10.1128/iai.58.2.515-522.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kunicki T. J., Newman P. J. Synthesis of analogs of human platelet membrane glycoprotein IIb-IIIa complex by chicken peripheral blood thrombocytes. Proc Natl Acad Sci U S A. 1985 Nov;82(21):7319–7323. doi: 10.1073/pnas.82.21.7319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McDevitt D., Francois P., Vaudaux P., Foster T. J. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol. 1994 Jan;11(2):237–248. doi: 10.1111/j.1365-2958.1994.tb00304.x. [DOI] [PubMed] [Google Scholar]
- Nicolau D. P., Freeman C. D., Nightingale C. H., Quintiliani R., Coe C. J., Maderazo E. G., Cooper B. W. Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infect Immun. 1993 Apr;61(4):1593–1595. doi: 10.1128/iai.61.4.1593-1595.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Packham M. A., Rand M. L., Kinlough-Rathbone R. L. Similarities and differences between rabbit and human platelet characteristics and functions. Comp Biochem Physiol Comp Physiol. 1992 Sep;103(1):35–54. doi: 10.1016/0300-9629(92)90239-m. [DOI] [PubMed] [Google Scholar]
- Phillips D. R., Charo I. F., Scarborough R. M. GPIIb-IIIa: the responsive integrin. Cell. 1991 May 3;65(3):359–362. doi: 10.1016/0092-8674(91)90451-4. [DOI] [PubMed] [Google Scholar]
- Ruggeri Z. M., Houghten R. A., Russell S. R., Zimmerman T. S. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5708–5712. doi: 10.1073/pnas.83.15.5708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scheld W. M., Valone J. A., Sande M. A. Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest. 1978 May;61(5):1394–1404. doi: 10.1172/JCI109057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schuhardt V. T., Klesius P. H. Osmotic fragility and viability of lysostaphin-induced staphylococcal spheroplasts. J Bacteriol. 1968 Sep;96(3):734–737. doi: 10.1128/jb.96.3.734-737.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Strong D. D., Laudano A. P., Hawiger J., Doolittle R. F. Isolation, characterization, and synthesis of peptides from human fibrinogen that block the staphylococcal clumping reaction and construction of a synthetic clumping particle. Biochemistry. 1982 Mar 16;21(6):1414–1420. doi: 10.1021/bi00535a048. [DOI] [PubMed] [Google Scholar]
- Sullam P. M., Costerton J. W., Yamasaki R., Dazin P. F., Mills J. Inhibition of platelet binding and aggregation by streptococcal exopolysaccharide. J Infect Dis. 1993 May;167(5):1123–1130. doi: 10.1093/infdis/167.5.1123. [DOI] [PubMed] [Google Scholar]
- Sullam P. M., Frank U., Yeaman M. R., Täuber M. G., Bayer A. S., Chambers H. F. Effect of thrombocytopenia on the early course of streptococcal endocarditis. J Infect Dis. 1993 Oct;168(4):910–914. doi: 10.1093/infdis/168.4.910. [DOI] [PubMed] [Google Scholar]
- Sullam P. M., Valone F. H., Mills J. Mechanisms of platelet aggregation by viridans group streptococci. Infect Immun. 1987 Aug;55(8):1743–1750. doi: 10.1128/iai.55.8.1743-1750.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tomiyama Y., Brojer E., Ruggeri Z. M., Shattil S. J., Smiltneck J., Gorski J., Kumar A., Kieber-Emmons T., Kunicki T. J. A molecular model of RGD ligands. Antibody D gene segments that direct specificity for the integrin alpha IIb beta 3. J Biol Chem. 1992 Sep 5;267(25):18085–18092. [PubMed] [Google Scholar]
- Wheat J., Kohler R. B., Garten M., White A. Commercially available (ENDO-STAPH) assay for teichoic acid antibodies. Evaluation in patients with serious Staphylococcus aureus infections and in controls. Arch Intern Med. 1984 Feb;144(2):261–264. [PubMed] [Google Scholar]
- White J. G. A biphasic response of platelets to serotonin. Scand J Haematol. 1970;7(3):145–151. doi: 10.1111/j.1600-0609.1970.tb01881.x. [DOI] [PubMed] [Google Scholar]
- Yeaman M. R., Sullam P. M., Dazin P. F., Norman D. C., Bayer A. S. Characterization of Staphylococcus aureus-platelet binding by quantitative flow cytometric analysis. J Infect Dis. 1992 Jul;166(1):65–73. doi: 10.1093/infdis/166.1.65. [DOI] [PubMed] [Google Scholar]